What is NDC 51525-5901?

51525-5901 is the product NDC for Carisoprodol, Carisoprodol 250 mg/1 tablet, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Mylan Pharmaceuticals Inc., NDC labeler code 51525. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Carisoprodol?

46 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Carisoprodol NDC 51525-5901 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51525-5901Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51525-5901Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51525-5901-1	5152559010151525590101	100 TABLET in 1 BOTTLE (51525-5901-1)Marketed from Oct 1, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carisoprodol
Generic name (nonproprietary): carisoprodol
Active ingredients: Carisoprodol — 250 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Mylan Pharmaceuticals Inc.NDC labeler code 51525
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 011792
Marketing start: Oct 1, 2016
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 51525-5901_8c92753a-4b60-4ecf-b411-d66665ae493eSPL ID 8c92753a-4b60-4ecf-b411-d66665ae493eSPL set ID 7c9184c0-7a2e-11df-8c8d-0002a5d5c51bRxCUI 730794UNII 21925K482H
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451525590101 followed by a unit qualifier and the quantity

Package 51525-5901-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 15, 2025.

Indications (excerpt from the label)

Carisoprodol tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Limitation of Use Carisoprodol tablets should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [ see Dosage and Administration (2) ] . Carisoprodol tablets are a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. (1) Limitations of Use • Should only be used for acute treatment periods up to two or three wee…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51525-5901

What is NDC 51525-5901?: 51525-5901 is the product NDC for Carisoprodol, Carisoprodol 250 mg/1 tablet, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Carisoprodol.
What is the active ingredient?: Carisoprodol.
Who is the labeler?: Mylan Pharmaceuticals Inc., NDC labeler code 51525. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Carisoprodol?: 46 other product NDCs are listed under this name. See all Carisoprodol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Carisoprodol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-397	60760-0397-90
Carisoprodol	Carisoprodol 250 mg/1	TabletOral	Westminster Pharmaceuticals, LLC	69367-419	69367-0419-01
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Westminster Pharmaceuticals, LLC	69367-420	69367-0420-0169367-0420-05
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Northwind Health Company, LLC	82868-062	82868-0062-30
carisoprodol	Carisoprodol 350 mg/1	TabletOral	REMEDYREPACK INC.	70518-3792	70518-3792-00
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0291	80425-0291-0180425-0291-0280425-0291-03
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Direct_Rx	72189-386	72189-0386-3072189-0386-7272189-0386-90
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Directrx	72189-310	72189-0310-3072189-0310-6072189-0310-72+1 more
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	REMEDYREPACK INC.	70518-2800	70518-2800-00
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Medsource Pharmaceuticals	45865-233	45865-0233-3045865-0233-60

All 47 Carisoprodol NDCs

Other NDCs under NDA 011792

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 011792
Product	Strength	Form · route	Labeler	Product NDC
Somacarisoprodol	Carisoprodol 350 mg/1	TabletOral	Viatris Specialty LLC	0037-2001
Somacarisoprodol	Carisoprodol 250 mg/1	TabletOral	Viatris Specialty LLC	0037-2250